DERMOSAFE
DermoSafe is a Swiss company that aims to bring innovative products and services for the management and early detection of melanoma. It offers a medical device supported by an innovative web service which connects primary care practitioners, patients, and specialists with one another. DermoSafe was founded by Philippe Held in November 2012 and is based in Cheseaux, Switzerland.
DERMOSAFE
Industry:
Health Care Medical Device Web Apps
Founded:
2012-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.dermosafe.com
Total Employee:
1+
Status:
Active
Contact:
+41 79 557 64 62
Total Funding:
698.21 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Nginx Amazon GStatic Google Static Content Facebook Conversion Tracking DoubleClick.Net CloudFront Google Adsense
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - DermoSafe
Foundation for Technological Innovation (FIT)
Foundation for Technological Innovation (FIT) investment in Debt Financing - DermoSafe
Official Site Inspections
http://www.dermosafe.com Semrush global rank: 4 M Semrush visits lastest month: 1.12 K
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "DermoSafe"
DermSafe – Hand Sanitizer
Our patented polymer delivery technology binds DermSafe® to your hands providing long-lasting protection, even after hand washing. It’s an added level of defense that protects you, your …See details»
DermoSafe - Crunchbase Company Profile & Funding
DermoSafe is a Swiss company that aims to bring innovative products and services for the management and early detection of melanoma. It offers a medical device supported by an …See details»
Ovation Science Ramps-Up Its Manufacturing of DermSafe as
Mar 19, 2020 /CNW/ - Ovation Science Inc. (CSE: OVAT) ("Ovation" or the "Company"), announces that due to the recent changes by Health Canada the Company has increased the...See details»
About DermSafe – DermSafe
DermSafe® is an antimicrobial hand sanitizer formulated with 4% chlorhexidine gluconate that has the unique ability to kill both bacteria and viruses, without the use of alcohol. It is the type …See details»
DermSafe Provides Ovation Science with New Revenue Stream …
Sep 9, 2020 VANCOUVER, BC / ACCESSWIRE / September 9, 2020 / (CSE:OVAT) - Ovation Science Inc.See details»
Ovation Science to Present at Annual Dermatology Update
Vancouver, BC – November 4th, 2020 Ovation Science Inc.(CSE:OVAT), a topical research and development company with a patented drug delivery technology backed by over 20 years of …See details»
Ovation Science’s Hand Sanitizer DermSafe now Manufactured in …
New Inventory of Pharmaceutical-Grade Hand Sanitizer Now Available VANCOUVER, BC / ACCESSWIRE / August 19, 2020 / Ovation Science Inc. (CSE:OVAT) ("Ovation" or the …See details»
Dermatology | Alto Pharma
DermSafe is made with 4% chlorhexidine gluconate, an ingredient used in hospitals worldwide due to its effectiveness against a wide range of germs and its persistence. DermSafe hand …See details»
Ovation Science : Receives Its First Order from China for Its …
Feb 14, 2020 Ovation Science Inc. , announces it has received an initial purchase order and full payment for 25,000 units of its DermSafe hand sanitizer lotion made with chlorhexidine …See details»
Ovation Science’s Hand Sanitizer DermSafe now Manufactured in …
Aug 19, 2020 New Inventory of Pharmaceutical-Grade Hand Sanitizer Now Available VANCOUVER, BC / ACCESSWIRE / August 19, 2020 / Ovation Science Inc.See details»
Skinvisible Announces License Agreement
Feb 13, 2020 This new license agreement for DermSafe represents an additional agreement with its own terms and conditions. "This is a great opportunity to have our DermSafe hand …See details»
Ovation Science Announces Expanded Distribution of DermSafe …
Ovation Science Announces Expanded Distribution of DermSafe Hand Sanitizer by DermSafe in News August 12, 2021 On-going Pandemic Has Raised Importance for Employers to …See details»
Canadian Athletes Choose Ovation Science's DermSafe Hand …
Return to Sports Begins as Canada Opens Up VANCOUVER, BC / ACCESSWIRE / June 28, 2021 / (CSE:OVAT)(OTC:OVATF) - Ovation Science Inc. ("Ovation" or the "Company") is …See details»
DermSafe Successfully Tested Against Human Coronavirus …
Jul 8, 2020 The study verified the effectiveness of DermSafe hand sanitizer made with chlorhexidine gluconate to kill a human beta coronavirus at time points of 1 and 5 minutes. ...See details»
Ovation Science Announces Extended Rights for DermSafe Hand …
Jun 15, 2020 Ovation Science Inc. announced it has signed a revised agreement for additional rights for its DermSafe hand sanitizer under the terms of the original License Agreement with …See details»
Ovation Science Signs Distribution Agreement for DermSafe for …
Its DermSafe hand sanitizer through an established medical distributor outside of North America. Gad Medical, founded in 2013, is based in Tel Aviv, Israel. They import and market healthcare …See details»
Ovation Science Announces Extended Rights For DermSafe Hand …
Vancouver, BC – June 15, 2020 (CSE: OVAT) – Ovation Science Inc. (“Ovation” or the “Company”) is pleased to announce it has signed a revised agreement for additional rights for …See details»
Skinvisible Signs License Agreement for DermSafe to Fight H1N1
Sep 24, 2009 Skinvisible, Inc. (SKVI:OTCBB), a pharmaceutical research and development company announced today that it has entered into an exclusive license agreement with …See details»
Our Science - DermSafe
Scientists have spent over 6 years developing and refining DermSafe hand sanitizer. The combination of chlorhexidine gluconate and Invisicare has resulted in a unique formulation that …See details»
DermSafe Successfully Tested Against Human Coronavirus
Jul 23, 2020 Ovation Science announces a proposed private placement offering of up to 4,000,000 units (each a “Unit”) at a price of $0.42 per Unit for total proceeds of up to …See details»